This trial is active, not recruiting.

Conditions abdominal aortic aneurysm, endoleak
Sponsor Norwegian University of Science and Technology
Collaborator St. Olavs Hospital
Start date September 2014
End date December 2016
Trial size 60 participants
Trial identifier NCT01843335, 2013/359/REKnord


X-ray computed tomography imaging (CT) is routinely used in follow-up after endovascular aneurysm repair (EVAR). Contrast-enhanced ultrasound (CEUS) has been shown to give accurate information about endoleak after EVAR. Benefits of CEUS over CT include less radiation exposure, avoidance of renal function deterioration due to repeated X-ray contrast agent application and decrease in the cost of EVAR follow-up. This study is designed to investigate if results from literature are reproducible in St Olavs Hospital in Trondheim (Norway), to gain experience with the technique and to introduce CEUS as an alternative for detection of endoleak in this hospital.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective

Primary Outcomes

Detection of endoleak with CEUS
time frame: 9 months

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - in follow-up after endovascular implantation of abdominal aortic prothesis Exclusion Criteria:

Additional Information

Official title Contrast-enhanced Ultrasound in Follow-up After Endovascular Aneurysm Repair
Trial information was received from ClinicalTrials.gov and was last updated in September 2016.
Information provided to ClinicalTrials.gov by Norwegian University of Science and Technology.